Responses
Regular Abstracts – Part 2
Clinical Trial In Progress
782-F Pseudoprogression and subsequent shrinkage of refractory/relapsed pediatric solid tumors induced by GAIA-102: an interim report of the single-agent cohort in Phase I clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
